Login to Your Account

TauRx Shows Strong Results Slowing Alzheimer's Progress

By Nuala Moran

Wednesday, July 30, 2008
LONDON - TauRx Therapeutics Ltd. presented positive data on the first tau inhibitor to complete Phase II in the treatment of Alzheimer's disease, showing the drug, rember, slowed the progress of the mild to moderate form of the disorder by 81 percent over 12 months. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription